Semax is a synthetic heptapeptide derived from ACTH (adrenocorticotropic hormone) developed by the Institute of Molecular Genetics in Russia. It is a potent nootropic and neuroprotective peptide extensively studied in preclinical models for its ability to enhance cognitive function, memory, focus, and neuroprotection through BDNF upregulation and neuromodulatory mechanisms.
Semax
$45.00Price
- Enhances memory, focus, and cognitive processing in preclinical animal models
- Neuroprotective: studied for ischaemic brain injury, TBI, and neurodegeneration in preclinical research
- Increases BDNF (brain-derived neurotrophic factor) expression in animal and in vitro models
- Dopaminergic and serotonergic modulation studied in preclinical mood and motivation research
- No reported addiction or dependence in preclinical research models
